this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->

Chemical Component Summary

Name1-PHENYL-2-AMINOPROPANE
Identifiers(2R)-1-phenylpropan-2-amine
FormulaC9 H13 N
Molecular Weight135.21 g/mol
TypeL-PEPTIDE LINKING
Isomeric SMILESC[C@@H](N)Cc1ccccc1
InChIInChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m1/s1
InChIKeyKWTSXDURSIMDCE-MRVPVSSYSA-N

Chemical Details

Formal Charge0
Atom Count23
Chiral Atom Count1
Chiral AtomsCA
Bond Count23
Aromatic Bond Count6
Leaving AtomsH2

Drug Info: DrugBank

DrugBank IDDB00182 Different stereochemistry
NameAmphetamine
Groups
  • approved
  • illicit
DescriptionAmphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. By mimicking the structures of the catecholamine neurotransmitters, noradrenaline and dopamine, amphetamines modulate monoamine release, reuptake, and signalling within the brain. Although "amphetamine" is used as a descriptor of its own structural class, amphetamine properly refers to a racemic free base composed of equal parts of its two optical antipodes: levo-amphetamine and dextro-amphetamine. Used in the past for the treatment of depression, stress, and for concentration improvement, it is currently available as a prescription drug for the treatment of attention hyperactivity disorder (ADHD), narcolepsy, and as an adjunct in the treatment of exogenous obesity. Amphetamine is also available in a mixed salt/mixed enantiomer form (Adderall), where d-amphetamine and l-amphetamine are available in a ratio of 3:1. It is also available in a prodrug form as lisdexamfetamine.
Synonyms
  • 1-phenyl-2-aminopropane
  • 1-Phenylpropan-2-amin
  • alpha-Methylbenzeneethaneamine
  • alpha-Methylphenylethylamine
  • Amfetamine
Salts
  • Amphetamine adipate
  • Amphetamine aspartate
  • Amphetamine aspartate monohydrate
  • Amphetamine sulfate
Brand Names
  • Act Amphetamine XR
  • Adderall
  • Adderall XR
  • Adzenys XR-odt
  • Apo-amphetamine XR
Affected OrganismHumans and other mammals
IndicationFor treatment of Attention Deficit Disorder with Hyperactivity (ADDH), narcolepsy, and exogenous obesity as a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction for patients refractory to alternative therapy.
Mechanism of actionAmphetamines stimulate the release of norepinephrine from central adrenergic receptors. At higher dosages, they cause release of dopamine from the mesocorticolimbic system and the nigrostriatal dopamine systems. Amphetamine may also act as a direct agonist on central 5-HT receptors and may inhibit monoamine oxidase (MAO). In the periphery, amphetamines are believed to cause the release of noradrenaline by acting on the adrenergic nerve terminals and alpha- and beta-receptors. Modulation of serotonergic pathways may contribute to the calming affect. The drug interacts with VMAT enzymes to enhance release of DA and 5-HT from vesicles. It may also directly cause the reversal of DAT and SERT.
Route of administrationOral
Categories
  • Adrenergic Agents
  • Adrenergic Uptake Inhibitors
  • Amines
  • Amphetamines
  • Autonomic Agents
ATC-CodeN06BA01
AHFS-Code28:20.04
CAS number300-62-9

Drug Targets

NameSequence SearchPharmacological ActionActions
Amine oxidase [flavin-containing] BMSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQK...unknown
Amine oxidase [flavin-containing] BMSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQK...unknown
Amine oxidase [flavin-containing] BMSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQK...yesinhibitor
Amine oxidase [flavin-containing] BMSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQK...yesinhibitor
Sodium-dependent dopamine transporterMSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNP...yesnegative modulator
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682